fda7c7e790d6ac8da374d8fa5932d962:101483b78505f3aecd5eabb59d60085f5cf9659ba9908944215190821269e8bbe56b0d9449bb0a9566024ac02f16472b6d0f49f01cd7f78c73c06000ae10fec2a129315cac7564da60e56b646e23d9eb7853989cc9c56d6382e87ec1593f58efd752671b3a5dd7986d6a055529d98cebfa15dc5f7bc1332c0014aff51dd6089aa6c308f18d6cf03d15ded71a63b051969327f30084411ca4ad064748f12d8a234765aa64f28a6b77332531963a8f6a596c71f608043be2e0e70cd70f966bf765ecfd3e4c445152dc009aa3f3851ed2ec40ee9c1805d800e794054ba7c3e822215d4962af2e5be557316c6a8aee9c1dab50c3b9348dfe34fb174e2afb9508c534925a825cc923aab13520230c4f1091aadc2222b665c1316e8b8ac03ae922eb263ec4c370b1e1cf94af1b83bf286c181c1e5fafdd1f5be3c3e2f69be433d1b729b33c979b6688d0f3aaee345817a198067fccc20d65e366c39f7095095dd25545e1920d10c0168e1c68c3c95879bcdc028b7b71779dffbcbf79658fefd31a371012b0c305695ed23f0d7b6c8179382787629fe49bcd12f41090d7270988421151687e20184a93f6c0